WeDoCRISPR
@wedocrispr.bsky.social
🌟Weekly insights from the genome editing word delivered in a funny and easy to access format, right at your fingertips! 🧬
@sniprbiome.bsky.social has officially dosed the first human patient in a clinical trial using CRISPR-armed bacteriophages to kill off antibiotic-resistant E. coli bacteria in patients with blood cancer. Read their full press release here: lnkd.in/ehwSKyB9
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
June 13, 2025 at 9:17 AM
@sniprbiome.bsky.social has officially dosed the first human patient in a clinical trial using CRISPR-armed bacteriophages to kill off antibiotic-resistant E. coli bacteria in patients with blood cancer. Read their full press release here: lnkd.in/ehwSKyB9